News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Keep the momentum going – KidneyCAN
KidneyCAN/X
Feb 8, 2025, 06:53

Keep the momentum going – KidneyCAN

KidneyCAN shared a post on LinkedIn:

“In 2016, Kidney Cancer research received $0 in dedicated federal funding.

Thanks to advocates like you, that number grew to $50 million in 2024. Keep the momentum going—join our Virtual Advocacy Day on March 11!

Register here!”

cancer fight against cancer Global fight against cancer kidney cancer research KidneyCAN OncoDaily Oncology Virtual Advocacy Day
Special Coverage
Blog
Mar 10, 2025, 06:12
Rachel Frizberg: Thrilled to kick things off as the new Global Head of Business Excellence at Roche Pharma
Blog
Mar 10, 2025, 06:05
Toufic Kachaamy: Advancing Endoscopic Oncology Through Education and Innovation
Blog
Mar 10, 2025, 05:46
Susan Pandya: A glimpse into what the next generation of innovators has in store for us
Science
Mar 9, 2025, 15:10
Patrick Hwu: Can a common pain reliever help fight cancer?
Blog
Mar 9, 2025, 15:01
Sami Mansfield: Racial disparities in recommending PI3K inhibitors in black women with mBC
Blog
Mar 9, 2025, 14:55
Guillermo Chantada: The life of the great Audrey Evans came to Hollywood
Blog
Mar 9, 2025, 14:54
Abstract submissions are opening for the 22nd SIO International Conference
Career
Mar 9, 2025, 14:48
Overview of ESMO: Advancing Cancer Research Through the ESMO Congress and Global Oncology Conferences
Blog
Mar 9, 2025, 14:43
The White House has officially declared March 2025 as National CRC Awareness Month - Fight Colorectal Cancer
Blog
Mar 9, 2025, 14:34
International Myeloma Foundation's Regional Community Workshop 2025
Blog
Mar 9, 2025, 14:27
Sakditad Saowapa: A bright future-rising oncologist from Pakistan is here
Insight
Mar 9, 2025, 14:19
Farah Tarek Shaalan: Knowledge and attitude toward cancer clinical trials in the Middle East and North Africa